Patent ID: 8748117
Filing Date: 2014-06-10
Classification: C12Q

Abstract:
1. A method for detecting and quantifying nitric oxide in vitro in a cell from an animal cell line or cultured somatic cells, which comprises: co-expressing in the cell a first hybrid protein consisting of an α-subunit of soluble guanylate cyclase and a first cGMP-visualization probe, and a second hybrid protein consisting of a β-subunit of soluble guanylate cyclase and a second cGMP-visualization probe, and forming a dimer of the first hybrid protein and the second hybrid protein; contacting the dimer of the first hybrid protein and the second hybrid protein with guanosine 5′-triphosphate in the cell; detecting a signal from the first cGMP-visualization probe and the second cGMP-visualization probe, wherein the signal indicates the presence of nitric oxide in the cell; and quantifying the amount of nitric oxide in the cell by comparison of the signal change with a calibration curve between nitric oxide concentrations and the signal changes, wherein the first cGMP visualization probe and second cGMP-visualization probe each comprise: a polypeptide that binds specifically to cyclic guanosine monophosphate (cGMP), wherein the polypeptide is cGMP-dependent protein kinase Iα in which amino acids 1-47 are deleted, and two chromophores, cyan fluorescent protein and yellow fluorescent protein, one of which is linked to the N-terminal of the polypeptide and the other of which is linked to the C-terminal of the polypeptide, and wherein the method is capable of detecting a 1 nanomolar concentration of nitric oxide in the cell.